Skip to content
healthcare.dev

INGREZZA

NDC 70370-2040, Valbenazine, capsule, from Neurocrine Biosciences, Inc..

Product NDC
70370-2040
Status
Listed
Labeler
Neurocrine Biosciences, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA209241
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70370-2040 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VALBENAZINE TOSYLATE40 mg/1

Pharmacologic classes

Vesicular Monoamine Transporter 2 Inhibitor [EPC]; Vesicular Monoamine Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
70370-2040-17037020400130 CAPSULE in 1 BOTTLE (70370-2040-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4c970164-cafb-421f-9eb5-c226ef0a3417
  • NADAC price for package 70370204001

    GET /v1/drugs/nadac/70370204001

Use it

Look up 70370-2040 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70370-2040 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70370-2040. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.